Register for real-time alerts, custom portfolio, and market movers
The current GIFLF market cap is 7.77B. The company's latest EPS is EUR and P/E is N/A.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 5.39B | 5B | 6.06B | 6.59B | 7.21B |
| Operating Income | 1.06B | 628.25M | 804.2M | 798.48M | 1.19B |
| Net Income | 618.55M | 182.8M | 208.28M | 59.32M | 156.92M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 15.27B | 19.23B | 21.53B | 21.44B | 21.41B |
| Total Liabilities | 8.55B | 11.09B | 13.08B | 13.47B | 12.8B |
| Total Equity | 6.72B | 8.15B | 8.46B | 7.97B | 8.61B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 1.11B | 596.98M | -10.87M | 208.28M | 902.17M |
| Investing | -858.12M | -29.39M | -1.98B | -397.64M | 886.67M |
| Financing | -354.4M | 1.47B | -173.49M | 186.05M | -1.36B |
| Market Cap | 7.77B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 687.55M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 67 |
| 52 Week Change | 33.57% |
| 52 Week High | 11.39 |
| 52 Week Low | 8.40 |
| Spread (Intraday) | 1.67 (14.77%) |
| Company Name | Grifols Sa (PK) |
| Address |
calle jesus i maria, 6 barcelona, catalonia 08174 |
| Website | https://www.grifols.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
